Joshua D. Stearns
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joshua D. Stearns.
Critical Care Clinics | 2008
Charles W. Hogue; Rebecca F. Gottesman; Joshua D. Stearns
Cerebral injury is a frequent complication of cardiac surgery, and it has been associated with high mortality, morbidity, hospital costs; an increased likelihood of admission to a secondary care facility after hospital discharge; and impaired quality of life. This article examines postulated mechanisms for cerebral injury from cardiac surgery. Most emphasis has been placed in the past on the intraoperative interval as being the period of highest cerebral vulnerability. Many clinical cerebral events, however, occur in the postoperative period.
Anesthesiology Clinics | 2008
Kelly L. Grogan; Joshua D. Stearns; Charles W. Hogue
Brain injury is a major source of patient morbidity after cardiac surgery, and is associated with prolonged hospitalization, excessive operative mortality, high hospital costs, and altered quality of life. Frequency and the clinical manifestations depend on multiple factors, including the completeness and timing of neurologic testing. Ischemic brain infarctions may or may not be associated with stroke or postoperative neurocognitive dysfunction, but the long-term implications of these lesions on neurologic function have not yet been extensively evaluated. This article reviews the current views on the pathophysiologic basis of cerebral injury after cardiac surgery and provides a summary of measures aimed at reducing its occurrence.
Anesthesia & Analgesia | 2009
Joshua D. Stearns; Victor G. Dávila-Román; Benico Barzilai; Richard E. Thompson; Kelly L. Grogan; Betsy Thomas; Charles W. Hogue
BACKGROUND: Adverse cardiac events that follow cardiac surgery are an important source of perioperative morbidity and mortality for women. Troponin I provides a sensitive measure of cardiac injury, but the levels after cardiac surgery may vary between sexes. Our purpose in this study was to evaluate the prognostic value of troponin I levels for predicting cardiovascular complications in postmenopausal women undergoing cardiac surgery. METHODS: The cohort of this study were women enrolled in a previously reported clinical trial evaluating the neuroprotective potential of 17&bgr;-estradiol in elderly women. In that study, 175 postmenopausal women not receiving estrogen replacement therapy and scheduled to undergo coronary artery bypass graft (with or without valve surgery) were prospectively randomized to receive 17&bgr;-estradiol or placebo in a double-blind manner beginning the day before surgery and continuing for 5 days postoperatively. Serial 12-lead electrocardiograms were performed and serum troponin I concentrations were measured before surgery, after surgery on arrival in the intensive care unit, and for the first four postoperative days. The primary end-point of the present study was major adverse cardiovascular events (MACE) defined as a Q-wave myocardial infarction, low cardiac output state or death within 30 days of surgery. The diagnosis of Q-wave myocardial infarction was made independently by two physicians blinded to treatment and patient outcomes with the final diagnosis requiring consensus. Low cardiac output state was defined as cardiac index <2.0 L · min−1 · m−2 for >8 h regardless of treatment. RESULTS: Troponin I levels on postoperative day 1 were predictive of MACE (area under the receiver operator curve = 0.862). A cutoff point for troponin I of >7.6 ng/mL (95% confidence interval, 6.4–10.8) provided the optimal sensitivity and specificity for identifying patients at risk for MACE. The negative predictive value of a troponin I level for identifying a patient with a composite cardiovascular outcome was high (96%) and the positive predictive value moderate (40%). Postoperative troponin I levels were not different between women receiving perioperative 17&bgr;-estradiol treatment compared with placebo and the frequency of MACE was not influenced by 17&bgr;-estradiol treatment. CONCLUSIONS: In postmenopausal women, elevated troponin I levels on postoperative day 1 are predictive of MACE. Monitoring of perioperative troponin I levels might provide a means for stratifying patients at risk for adverse cardiovascular events.
Intensive Care Medicine | 2009
Charles W. Hogue; Joshua D. Stearns; Elizabeth Colantuoni; Karen A. Robinson; Tracey L. Stierer; Nanhi Mitter; Peter J. Pronovost; Dale M. Needham
Journal of Clinical Anesthesia | 2006
Jeffrey M. Richman; Joshua D. Stearns; Andrew J. Rowlingson; Christopher L. Wu; Edward G. McFarland
Anesthesia & Analgesia | 2007
Brenda MacKnight; Joshua D. Stearns; Luca A. Vricella; Jon R. Resar
international symposium on biomedical imaging | 2010
Francisco Contijoch; Laura Fernandez-de-Manuel; Tri Ngo; Joshua D. Stearns; Kelly L. Grogan; MaryBeth Brady; Philippe Burlina; Andrés Santos; David D. Yuh; Daniel A. Herzka; Maria J. Ledesma-Carbayo; Elliot R. McVeigh
Archive | 2011
Joshua D. Stearns; Charles W. Hogue
Johns Hopkins APL Technical Digest (Applied Physics Laboratory) | 2010
C. Sprouse; Anne Jorstad; Daniel DeMenthon; Philippe Burlina; Francisco Contijoch; Tri Ngo; Daniel A. Herzka; Elliot R. McVeigh; Joshua D. Stearns; Kelly L. Grogan; MaryBeth Brady; Theodore P. Abraham; David D. Yuh
Anesthesia & Analgesia | 2007
Joshua D. Stearns; Wilson Y. Szeto; Albert T. Cheung